UBS Group’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.62M | Sell |
650,281
-54,712
| -8% | -$810K | ﹤0.01% | 2441 |
|
|
2025
Q1 | $12.6M | Sell |
704,993
-4,364
| -0.6% | -$78.2K | ﹤0.01% | 2166 |
|
|
2024
Q4 | $12.4M | Buy |
709,357
+383,122
| +117% | +$6.67M | ﹤0.01% | 2162 |
|
|
2024
Q3 | $4.56M | Buy |
326,235
+194,729
| +148% | +$2.72M | ﹤0.01% | 2353 |
|
|
2024
Q2 | $1.08M | Sell |
131,506
-241,105
| -65% | -$1.98M | ﹤0.01% | 3338 |
|
|
2024
Q1 | $2.87M | Buy |
372,611
+196,131
| +111% | +$1.51M | ﹤0.01% | 2674 |
|
|
2023
Q4 | $1.59M | Buy |
176,480
+103,295
| +141% | +$929K | ﹤0.01% | 3050 |
|
|
2023
Q3 | $654K | Sell |
73,185
-62,137
| -46% | -$556K | ﹤0.01% | 3422 |
|
|
2023
Q2 | $2.08M | Buy |
135,322
+9,537
| +8% | +$146K | ﹤0.01% | 2656 |
|
|
2023
Q1 | $2.83M | Sell |
125,785
-84,329
| -40% | -$1.9M | ﹤0.01% | 2280 |
|
|
2022
Q4 | $4.42M | Buy |
210,114
+167,838
| +397% | +$3.53M | ﹤0.01% | 1939 |
|
|
2022
Q3 | $1.04M | Sell |
42,276
-59,490
| -58% | -$1.46M | ﹤0.01% | 2826 |
|
|
2022
Q2 | $2.47M | Sell |
101,766
-51,550
| -34% | -$1.25M | ﹤0.01% | 2249 |
|
|
2022
Q1 | $3.95M | Sell |
153,316
-10,890
| -7% | -$281K | ﹤0.01% | 2118 |
|
|
2021
Q4 | $5.1M | Buy |
164,206
+163,607
| +27,313% | +$5.08M | ﹤0.01% | 2074 |
|
|
2021
Q3 | $14K | Sell |
599
-13,725
| -96% | -$321K | ﹤0.01% | 6459 |
|
|
2021
Q2 | $209K | Sell |
14,324
-35,958
| -72% | -$525K | ﹤0.01% | 4290 |
|
|
2021
Q1 | $1.26M | Buy |
50,282
+48,860
| +3,436% | +$1.22M | ﹤0.01% | 3155 |
|
|
2020
Q4 | $38K | Buy |
+1,422
| New | +$38K | ﹤0.01% | 5431 |
|
|
2020
Q3 | – | Sell |
-237
| Closed | -$5K | – | 7395 |
|
|
2020
Q2 | $5K | Sell |
237
-10,388
| -98% | -$219K | ﹤0.01% | 6527 |
|
|
2020
Q1 | $155K | Sell |
10,625
-22,998
| -68% | -$336K | ﹤0.01% | 4078 |
|
|
2019
Q4 | $477K | Sell |
33,623
-129,557
| -79% | -$1.84M | ﹤0.01% | 3932 |
|
|
2019
Q3 | $1.89M | Buy |
163,180
+140,411
| +617% | +$1.63M | ﹤0.01% | 2653 |
|
|
2019
Q2 | $458K | Buy |
22,769
+22,418
| +6,387% | +$451K | ﹤0.01% | 3596 |
|
|
2019
Q1 | $8K | Sell |
351
-40,050
| -99% | -$913K | ﹤0.01% | 6118 |
|
|
2018
Q4 | $914K | Buy |
40,401
+34,023
| +533% | +$770K | ﹤0.01% | 3055 |
|
|
2018
Q3 | $183K | Buy |
6,378
+6,073
| +1,991% | +$174K | ﹤0.01% | 4299 |
|
|
2018
Q2 | $8K | Sell |
305
-36,752
| -99% | -$964K | ﹤0.01% | 6352 |
|
|
2018
Q1 | $829K | Buy |
37,057
+35,874
| +3,032% | +$803K | ﹤0.01% | 3168 |
|
|
2017
Q4 | $25K | Sell |
1,183
-10,498
| -90% | -$222K | ﹤0.01% | 5419 |
|
|
2017
Q3 | $290K | Buy |
11,681
+10,599
| +980% | +$263K | ﹤0.01% | 3785 |
|
|
2017
Q2 | $21K | Buy |
1,082
+582
| +116% | +$11.3K | ﹤0.01% | 5325 |
|
|
2017
Q1 | $9K | Sell |
500
-23,436
| -98% | -$422K | ﹤0.01% | 5760 |
|
|
2016
Q4 | $453K | Buy |
23,936
+22,226
| +1,300% | +$421K | ﹤0.01% | 3392 |
|
|
2016
Q3 | $38K | Sell |
1,710
-38,807
| -96% | -$862K | ﹤0.01% | 4864 |
|
|
2016
Q2 | $721K | Buy |
40,517
+39,717
| +4,965% | +$707K | ﹤0.01% | 2917 |
|
|
2016
Q1 | $11K | Sell |
800
-64,964
| -99% | -$893K | ﹤0.01% | 5764 |
|
|
2015
Q4 | $1.27M | Buy |
65,764
+64,964
| +8,121% | +$1.25M | ﹤0.01% | 2527 |
|
|
2015
Q3 | $16K | Sell |
800
-463
| -37% | -$9.26K | ﹤0.01% | 5627 |
|
|
2015
Q2 | $42K | Buy |
+1,263
| New | +$42K | ﹤0.01% | 4893 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6798 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6797 |
|